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Background. Tuberculosis is a historically stigmatized disease and the stigma associated with it affects the institution, community,
and interpersonal factors.Therefore, understanding tuberculosis-related perceived stigma has importance in improving quality of
the patients. Objective. The aim of this study was to assess prevalence and factors associated with perceived stigma among patients
with tuberculosis attending Wolaita Sodo University Referral Hospital, Ethiopia. Methods. Institution based cross-sectional study
was conducted among a total of 417 tuberculosispatients who had treatment follow-up atTB clinics andwere recruited for the study.
Systematic random sampling technique was used to recruit study participants. A 12-item perceived TB stigma scale was used to
assess tuberculosis-related perceived stigma. In addition, Oslo social support scale was used to assess social support related factors.
Results. Prevalence of tuberculosis-related perceived stigma by using perceived tuberculosis stigma scale was 42.4%. Patients who
had pulmonary TB [AOR=2.49, (95% CI: 1.24, 4.87)], being intensive phase category [AOR=1.42, (95% CI: 1.19, 2.58)], TB/HIV
coinfection [AOR= 3.54, (95% CI: 1.37, 9.12)], poor social support [AOR=2.45, (95% CI: 1.18, 5.09)], and using substance (alcohol,
khat and cigarette) [AOR=1.78, (95% CI: 1.28, 3.17)] were more likely to have perceived TB stigma when compared to their counter
parts. Conclusion. Health education programs should be conducted to reduce TB stigma and improve patients’ compliance.
1. Introduction
Tuberculosis (TB) is one of chronic infectious disease which
is caused by Mycobacterium tuberculosis and becomes the
leading causes of morbidity and mortality worldwide [1, 2].
It is a key public health concern in Ethiopia: in 2009/2010, it
was the second most important cause of death [3]. Ethiopia
is ranked seventh among the 22 high-burden countries that
account for 81% of all cases of TB and 80% of all TB deaths
worldwide [4]. Ethiopia is also one of the 27 countries
identified as having a high prevalence of multidrug-resistant
TB (MDR-TB). The burden of MDR-TB in these countries
accounts for 86% of cases worldwide [3, 5].
Stigma stands as decreasing attribute which arises from
social interaction and is related to the power dominance and
difference [6]. Social (enacted) stigma refers to experience
discrimination by other people which results from inferiority
in the society while perceived stigma refers to the shame
and expectation of discrimination that prevents people from
talking about their experiences and sense of unworthy and
guilty [7–19]. TB is highly stigmatized disease which can be
experienced and felt at a different social setting like home,
workplace, and community [7].
Perceived stigma has a considerable impact on health
that renders patients to refuse disease and medical services
through discouraging health-seeking behavior which leads to
distortion of health condition making difficult to treat that
increases infectivity and communicability of the disease [7–
13]. It is more common in patients with tuberculosis. Some
studies conducted in Egypt Chest Hospital and in southern
Thailand and Nepal showed that the prevalence of perceived
stigma was 41.5 % and 63.3%, respectively [20–22].
Therefore, understanding tuberculosis-related perceived
stigma has importance in improving the quality of these
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populations. Therefore, this aimed to assess prevalence and
associated factors of perceived stigma among TB patients in
Ethiopia.
2. Methods
2.1. Study Setting and Population. Institution based cross-
sectional study design was conducted from March 2016
to May 2016 at Wolaita Sodo University Referal Hospital,
Woliata Sodo, Ethiopia. Tuberculosis patients whose ages
were ≥ 18 years were included in the study, while critically
ill patients were excluded from the study. Single population
proportion formula was used to get the required sample size.
Because there was no prior study on the subject area, to get
maximum sample size we used prevalence of perceived TB
stigma as 50% (P=50%), 95% CI, margin error of 5%, and
10% none-response rate; the required sample size became
424. Seven patients were excluded from the study due to
critical condition of the illness. Among tuberculosis patients
who had treatment follow-up TB clinics during the study
period in the mentioned hospital, we had recruited 417
tuberculosis patients. Systematic random sampling technique
was employed to select the study participants.
2.2. Data Collection. Our data collection instruments had
included a structured interviewer administered question-
naires on sociodemographic characteristic which mainly
focuses on age, sex, education, occupation, marital status,
religious view of the study participants, and others. We have
also used Oslo item 3 social support scales which is 3-item
questionnaire commonly used to assess social support related
issues in clinical and community settings [23].The variable of
interest (outcome variable), TB stigma felt byTBpatients, was
collected by 12-item perceived TB stigma scale that consisted
of four-point Likert scale questions concerning perceived
isolation, guilt, shame, and disclosure of their tuberculosis
status. It was validated in Thailand among TB and HIV
patients; its goodness-of-fit was good (TLI = 94, LFI =
0.88, and RMSEA = 0.11), internal consistency was excellent
(Cronbach's alphas 0.82-0.91), and test-retest reliability was
moderate. It has good psychometric properties that measure
stigma associated with tuberculosis and HIV/AIDS and
allow assessment of stigma from community and patient
perspectives. Participants were classified as having or not
having perceived stigmausing themeanof the stigma variable
as cut-off point [21]. This scale was adopted and translated to
Amharic language and it was highly reliable in the study with
Cronbach’s 𝛼 of 0.95.
2.3. Data Processing and Analyses. We used SPSS version
22 to analyze the data. The association of each independent
variable with perceived tuberculosis stigma was examined
in bivariate analysis. Those confounding variables that could
potentially be associated with both TB and perceived stigma
like anxiety, depression, substance use, social support, and
other variables with p value less than 0.2 during bivariate
analysis were entered into themultivariate analysis to identify
potential confounders. A p value of less than 0.05 was
considered statistically significant, and adjusted odds ratio
with 95% CI was calculated to determine association.
3. Results
3.1. Sociodemographic Characteristics of the Study Partici-
pants. Thestudy recruited a total of 417 tuberculosis patients;
themean (±SD) age of the respondents was 32.3 years (±9.23).
Concerning sociodemographic characteristics, 241 (57.8 %)
were male, 189 (45.3%) were from protestant religious back-
ground, and 199 (47.7 %)were never married. In addition, 287
(68.8 %) patients were diagnosed with pulmonary TB, 270
(64.9 %) were in intensive phase of TB treatment, and 229
(54.9%) had good social support (Table 1).
3.2. Prevalence of Perceived Stigma and Associated Factors
among the Study Participants. Prevalence of tuberculosis-
related perceived stigma by using Perceived Tuberculosis
stigma scale was 42.4%. Prevalence of isolation, guilt, dis-
closure, and their relationship to social support is 42.4
%, 37.9%, 40.1%, and 36.6 %, respectively. Using of binary
logistic regression analysis revealed that having pulmonary
TB (AOR=2.49, CI:(1.24, 4.87), (P<0.01)), being in intensive
phase of tuberculosis treatment (AOR=1.42, CI: (1.19, 2.58),
(P=0.02)), having comorbid HIV illness (AOR=3.54, CI:(1.37,
9.12), (P <0.01)), having poor social support (AOR=2.45,CI:
(1.18, 5.09) (P <0.01)), and current substance use (AOR=1.78,
CI:(1.28, 3.17), (P = 0.01)) (Table 2).
4. Discussion
Prevalence of TB related perceived stigma in the current
study was 42.4% (95%, CI: 39.28-45.52). This finding is in
agreement with study conducted in Egypt Chest Hospital and
southern Thailand [20, 21]. Nevertheless, a study result was
lower than study conducted in Nepal [22]. This difference
might be related to variation in study design, data collection
tool, sample size, and study participant’s variation. The
difference also attributed due to variation in culture which
is supported by findings from a systematic review and other
studies that revealed cultural variations is potential for stigma
[24–26].
Perceived stigma was mostly prevalent in patients with
pulmonary tuberculosis when compared to those who had
extra pulmonary tuberculosis. In addition to this, there was
significant association between TB related perceived stigma
and intensive phase of treatment. This finding is in agreement
with the other study [22]. TB related perceived stigma is
often a product of exaggerated notions of contagiousness.
Community awareness and patient education may help to
mitigate the isolation and rejection of TB patients and
encourage TB suspects to seek initial care.
Tuberculosis patients who had comorbid HIV infection
were more likely to have perceived stigma. This might be
evidenced by having diagnosed with HIV illness by itself
associated with high levels of stigma. Hence, TB/HIV coin-
fected patients can be at higher risk of having perceived
stigma [27, 28].
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Table 1: Sociodemographic and clinical characteristics of TB patients on follow-up at Wolaita Sodo University Hospital, Wolaita Sodo,
Ethiopia, 2016.
Variables Frequency Percent (%)
Age 18-24 years 96 21
25-49 years 226 70
>= 50 years 38 9
Sex Male 241 58
Female 176 42
Marital status Married 182 44
Single 199 48
Divorced/Widowed 66 9
Education status No formal education 78 19
Grade 1-8 129 31
Grade 9-12 116 28
College and above 94 23
Duration of illness < 6 months 25 6
6 – 12 months 247 59
>= 12 months 145 35
Phase of treatment Intensive phase 270 65
Continuation phase 147 35
Co-morbid chronic illness HIV/AIDS 49 12
Diabetes/Hypertension 24 6
No co-morbid illness 344 83
Social support Good 229 55
Poor 188 45
Depressive symptoms Yes 181 43
No 236 57
Anxiety symptoms Yes 173 41
No 244 59
Substance (khat, cigarette & alcohol) use Yes 30 7
No 387 93
Table 2: Factors associated with TB related perceived stigma among patients with TB at Wolaita Sodo University Referral Hospital, Wolaita
Sodo, Ethiopia, 2016, n=417.
Explanatory Variables Perceived TB stigma COR,95% (CI) AOR,95% (CI)Yes No
Age
18-24 23 65 0.21, (0.09, 1.47)
25-49 130 161 0.47, (0.23, 1.03)
50 and above 24 14 1 1
Sex Male 96 145 1 1Female 81 95 1.29, (1.09, 2.97)
Educational status
No formal education 45 33 1.97, (1.07, 3.63)
Grade 1-8 48 81 0.84, (0.50, 1.48)
Grade 9-12 45 71 0.94, (0.54, 1.63)
College and above 39 55 1 1
Job
Civil servant 33 43 1 1
Non-governmental 33 52 1.59, (0.84, 2.99)
Merchant 23 28 1.31, (0.71, 2.41)
Farmer 8 7 1.70, (0.84, 3.45)
House wives 27 25 2.37, (0.78, 7.15)
Jobless/Daily labors 29 60 4.35, (2.08, 8.11)
Classification Pulmonary TB 147 140 3.50, (2.19, 5.56) 2.49, (1.24, 4.87) ∗∗Extra pulmonary TB 30 100 1 1
Phase of treatment Intensive phase 75 134 1.97, (1.29, 4.56) 1.42, (1.19, 2.58) ∗Continuous phase 102 106 1 1
Co-morbid chronic illness
HIV/AIDS 36 13 4.85, (2.48, 9.49) 3.54, (1.37, 9.12) ∗∗
Diabetes/Hypertension 16 8 3.50, (1.45, 8.42)
No chronic illness 177 219 1 1
Social support Good 42 187 1 1Poor 135 53 11.34, (7.15, 17.99) 2.45, (1.18, 5.09) ∗∗
Substance (Cigarette, khat and alcohol) use Yes 51 28 2.87, (2.12, 4.18) 1.78, (1.28, 3.17) ∗No 131 207 1 1
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The study also showed that those patients who had poor
social support were significantly associated with perceived
stigma. Having poor social support and somatic illness may
lead to increased psychological distress [29]. Tuberculosis
patients who had family history of mental illness were more
likely to have perceived stigma. This finding was consistent
with other findings [20, 30].This might be due to the fact that
anxious patients aremore prone to use substances like alcohol
and cigarette to relief themselves from the internalized
stigma.
Study conducted in Nigeria among patients with pul-
monary tuberculosis showed that no formal education and
patients who are in the working age group of 20 to 50 years
had perceived TB stigma. Nevertheless, in this study there is
no statistically significant association.
5. Conclusion
Prevalence of Tuberculosis-related perceived stigma by using
perceived tuberculosis stigma scale was high (42.4%). Having
pulmonary TB, being in intensive phase of tuberculosis
treatment, having comorbid HIV illness, having poor social
support, and using substances like alcohol and cigarette
were associated with perceived stigma. Health professionals
who are working TB clinics should give more emphasis
to their patients and giving psychosocial counseling daily
basis is recommended. Health education programs should
be conducted to reduce TB stigma and improve patients’
compliance.
6. Limitation of the Study
This study did not do detailed validation study for perceived
HIV related-stigma scale and Oslo 3-item social support
scale. We did not include BMI in our assessment.
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